Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
57,000
Employees57,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
57,000
Employees57,000

DGX Key Statistics

Market cap
21.36B
Market cap21.36B
Price-Earnings ratio
21.53
Price-Earnings ratio21.53
Dividend yield
1.67%
Dividend yield1.67%
Average volume
818.20K
Average volume818.20K
High today
$196.00
High today$196.00
Low today
$192.35
Low today$192.35
Open price
$194.05
Open price$194.05
Volume
857.67K
Volume857.67K
52 Week high
$213.50
52 Week high$213.50
52 Week low
$164.65
52 Week low$164.65

Stock Snapshot

Quest Diagnostics(DGX) stock is priced at $192.88, giving the company a market capitalization of 21.36B. It carries a P/E multiple of 21.53 and pays a dividend yield of 1.7%.

On 2026-05-26, Quest Diagnostics(DGX) stock traded between a low of $192.35 and a high of $196.00. Shares are currently priced at $192.88, which is +0.3% above the low and -1.6% below the high.

The Quest Diagnostics(DGX)'s current trading volume is 857.67K, compared to an average daily volume of 818.2K.

In the last year, Quest Diagnostics(DGX) shares hit a 52-week high of $213.50 and a 52-week low of $164.65.

In the last year, Quest Diagnostics(DGX) shares hit a 52-week high of $213.50 and a 52-week low of $164.65.

DGX News

Simply Wall St 10h
A Look At Quest Diagnostics Valuation After Strong Q1 Beat And Raised Full Year Guidance

Quest Diagnostics (DGX) is back in focus after a strong first quarter, with revenue and adjusted earnings per share ahead of expectations, and management liftin...

A Look At Quest Diagnostics Valuation After Strong Q1 Beat And Raised Full Year Guidance
Simply Wall St 4d
Is Quest’s Strong Q1 Beat and Raised 2026 Outlook Altering The Investment Case For Quest Diagnostics?

Earlier this month, Quest Diagnostics reported first-quarter 2026 adjusted earnings per share of US$2.50 and revenue of US$2.90 billion, both ahead of analyst e...

Is Quest’s Strong Q1 Beat and Raised 2026 Outlook Altering The Investment Case For Quest Diagnostics?
TipRanks 5d
Quest Diagnostics Shareholders Back Board, Pay and Auditor

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

52%

of 21 ratings
Buy
47.6%
Hold
52.4%
Sell
0%

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.